NCT00156156View on ClinicalTrials.gov

Study of Asoprisnil in the Treatment of Uterine Fibroids.

PHASE3CompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Fibroid UterusLeiomyomaMenorrhagiaMetrorrhagiaUterine Fibroids
Interventions
DRUG

Asoprisnil

Asoprisnil 10 mg Tablet, oral Daily for up to 2 years

DRUG

Asoprisnil

Asoprisnil 25 mg Tablet, oral Daily for up to 2 years

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY